Advanced Filters
noise
Found 1,621 clinical trials
L Laura LA Albaladejo

Impact of Dietary Knowledge Related to Functional Insulin Therapy in Type 1 Diabetes on the Risk of Eating Disorders

Background: The management of type 1 diabetes (T1D) relies on exogenous insulin administration to compensate for the lack of endogenous insulin production. Optimal glycemic control, essential for preventing long-term complications, requires precise insulin dose adjustments based on carbohydrate intake. Functional insulin therapy (FIT) allows for flexibility in insulin dosing according …

18 years of age All Phase N/A
A Alona Hamou, Msc

The Israeli Study for Islet Autoantibodies Screening in Families of Type-1 Diabetes Patients

We aim at establishing a research program that will offer screening for the presence of Islet Autoantibodies (IA) in relatives of people with Type 1 Diabetes (T1D). Relatives of people with diabetes, children, and adults from our clinic and all over Israel will be offered to participate in the study. …

2 - 45 years of age All Phase N/A
A Anna de Carteret

Capillary OGTT Study

Type 1 diabetes (T1D) is a chronic condition, affecting 1 in 490 children under the age of 15 years. It is caused by the immune system damaging the pancreas, the organ which makes insulin. T1D has recognised stages before symptoms develop, providing an opportunity for early diagnosis, education and treatment …

- 17 years of age All Phase N/A
R Remi Rabasa-Lhoret

Glycemic Control and Osteohealth in Adults Living With Type 1 Diabetes

Bone damage is frequently observed in type 1 diabetes, and hyperglycemia is associated with an increased risk of fracture. This pilot study in 25 people living with type 1 diabetes aims to determine whether the introduction of an automated insulin delivery (AID) system improves bone markers through rapide optimization of …

18 - 100 years of age All Phase N/A
M Maria Chatzipsalti

Fake Carbs Practice With AID System - MiniMed 780G in Children and Adolescents With T1D.

Hybrid Closed Loop (HCL) systems, such as the MiniMed 780G, have significantly improved glycemic outcomes in Type 1 Diabetes (T1D) management. The MiniMed 780G, an Advanced Hybrid Closed Loop (AHCL) system, features autocorrection boluses and unique insulin adjustment technologies. While effective, the system requires user input for meal announcements. Some …

7 - 19 years of age All Phase N/A

Home-based Oral Glucose Tolerance Test for Type 1 Diabetes Screening

This study aims at quantifying the accuracy of a self-administered fingerstick based glucose tolerance test (GTT@Home) respect to the gold-standard in-clinic venous plasma measures during the oral glucose tolerance test (OGTT) across a wide range of glycemic values in people at risk for clinical type 1 diabetes (T1D) (carriers of …

8 - 45 years of age All Phase N/A
E Erin Cobry, MD

Accuracy of Continuous Glucose Monitors During the Perioperative Period in Youth With Type 1 Diabetes

This study is assessing the accuracy of continuous glucose monitors during surgical procedures requiring anesthesia.

2 - 26 years of age All Phase N/A
G Giulio Maltoni, MD

Clinical and Laboratory Characteristics of a Population of Children and Adolescents With Newly Diagnosed Type 1 Diabetes and Insulin Requirements at Onset

The clinical implication of this study lies in the identification of factors that may predict reduced insulin sensitivity in children and adolescents at the onset of Type 1 Diabetes and would help the physician to undertake appropriate therapy more quickly by achieving the correct therapeutic dosage, in order to achieve …

- 14 years of age All Phase N/A
I Ignacio González Maroto

Clinical Utility of Tight Objectives of Advanced Hybrid Closed-loop Systems Among Type 1 Diabetes Patients (TightT1AHCL)

Diabetes is a chronic disease with a relevant public health burden. Maintaining blood glucose levels as close to normal as possible is essential to avoid the associated microvascular and macrovascular complications. Therefore, the key to prevent and/or reduce the development of these chronic complications lies in an adequate and strict …

18 - 99 years of age All Phase N/A
D Dorota Zozulinska-Ziolkiewicz, Prof

Insulin Therapy and Lipoproteins' Profile in Type 1 Diabetes.

The aim of the study is to evaluate the effect of insulin therapy in patients with newly diagnosed type 1 diabetes on quantitative and qualitative changes of plasma lipoproteins, with particular emphasis on HDL metabolism, and analysis of the factors determining the effect of insulin therapy on lipid profile.The study …

18 - 35 years of age All Phase N/A

Simplify language using AI